Fingerprint
Dive into the research topics of 'Phase II study of gemcitabine, oxaliplatin, and cetuximab in advanced pancreatic cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II study of gemcitabine, oxaliplatin, and cetuximab in advanced pancreatic cancer
Jaime R. Merchan, Annaporna Ferrell, Jessica MacIntyre, Kristen K. Ciombor, Joe Levi, Afonso Ribeiro, Danny Sleeman, Aurea Flores, Gilberto Lopes, Caio M. Rocha-Lima
Research output: Contribution to journal › Article › peer-review
15
Scopus
citations